Authors

Claudia Martin Diaz, Miami Cancer InstituteFollow
Eduardo Guizan Corrales, Miami Cancer InstituteFollow
Felipe De Los Rios La Rosa, Miami Neuroscience InstituteFollow
Heidi Clarke, Baptist Hospital of MiamiFollow
Jonatha Kline, Baptist Hospital of MiamiFollow
Sylvia Marrero, Baptist Hospital of MiamiFollow
Radhan Gopalani, Baptist Hospital of MiamiFollow
Star Belnap, Miami Neuroscience InstituteFollow

Timing of anticoagulation therapy in patients admitted with a primary diagnosis of ischemic stroke or transient ischemic attack due to non-valvular atrial fibrillation

Publication Date

12-2019

Presented At:

2019 ASHP Midyear Clinical Meeting

Content Type

Poster

Resident/Fellow

Claudia Martin Diaz - Pharmacy Resident PGY1

Eduardo Guizan Corrales - Pharmacy Resident PGY1

Author Credentials

Claudia Martin Diaz, Pharm.D

Eduardo A. Guizan Corrales, Pharm.D

Felipe De Los Rios La Rosa, M.D.

Heidi Clarke, Pharm.D, BCCCP

Jonathan Kline, Pharm.D, BCCCP

Sylvia Marrero, Pharm.D, BCPS

Radhan Gopalani, Pharm.D, BCPS

Citation

Martin Diaz, Claudia; Guizan Corrales, Eduardo; De Los Rios La Rosa, Felipe; Clarke, Heidi; Kline, Jonatha; Marrero, Sylvia; Gopalani, Radhan; and Belnap, Star, "Timing of anticoagulation therapy in patients admitted with a primary diagnosis of ischemic stroke or transient ischemic attack due to non-valvular atrial fibrillation" (2019). All Publications. 3482.
https://scholarlycommons.baptisthealth.net/se-all-publications/3482